Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Comparison of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Treated With Disease Modifying Treatments (Dmt) In Europe (Eu) And The United States (Us).
Conformational Changes and Association of Membrane-Interacting Peptides in Myelin Membrane Models: A Case of the C-Terminal Peptide of Proteolipid Protein and the Antimicrobial Peptide Melittin.
Health-related quality of life in multiple sclerosis: role of cognitive appraisals of self, illness and treatment.
Identifying clues to molecular etiology of multiple sclerosis in South Indian patients.
Absence of MxA induction is related to a poor clinical response to interferon beta treatment in multiple sclerosis patients.
Tumour suppressor death-associated protein kinase targets cytoplasmic HIF-1α for Th17 suppression.
Analysis of humoral immune responses to LM1 ganglioside in guinea pigs.
Chronic inflammatory demyelinating polyneuropathy associated with alopecia totalis and Sjögren syndrome.
Infectious and noninfectious granulomatosis in patient with multiple sclerosis: diagnostic dilemmas and followup.
Impact of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod: Subgroup analyses of the Fingolimod Research Evaluating Effects of Daily Oral Therapy in Multiple Sclerosis (FREEDOMS) study.
Novel p75 neurotrophin receptor ligand stabilizes neuronal calcium, preserves mitochondrial movement and protects against HIV associated neuropathogenesis.
[Chronic inflammatory demyelinating polyradiculoneuropathy(CIDP): Treatment and prognosis].
Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
New Perspectives in Pediatric Neurology-Multiple Sclerosis.
A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
Admission sodium level and prognosis in adult Guillain-Barré syndrome.
How Fatigue Influences Exercise Participation in Men With Multiple Sclerosis.
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.
Unilateral internuclear ophthalmoplegia after minor head injury.
Neurosarcoidosis: Clinical Features, Diagnosis, and Management.
Icariin has synergistic effects with methylprednisolone to ameliorate EAE via modulating HPA function, promoting anti-inflammatory and anti-apoptotic effects.
T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO).
Demyelinating diseases in Asia.
Short-Term Effect of BalanceWear Therapy on Mobility in Older Adults With Mobility Limitations.
The relationship between the rate of brain volume loss during first 24 months and disability progression over 24 and 48 months in relapsing MS.
Pages
« first
‹ previous
…
715
716
717
718
719
720
721
722
723
…
next ›
last »